生化基因(BIIB)股吧_生化基因怎么样_分析讨论社区

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
98	0	优时比与百健(BIIB.US)狼疮新药dapirolizumab pegol三期临床试验达主要终点	智通财经	06-01 03:16
125	0	RBC Capital上调渤健目标价至227美元	格隆汇	05-28 11:19
27	0	成都先导发来贺电	黄衫倦客	05-27 10:23
37	0	[Amend] General Statement of Acquisition of Beneficial Ownership	生化基因资讯	05-15 04:40
34	0	Current report, items 1.01, 2.01, 2.03, 7.01, and 9.01	生化基因资讯	05-14 08:35
35	0	[Amend] Tender offer statement by Third Party	生化基因资讯	05-14 07:55
43	0	[Amend] Tender offer statement by Third Party	生化基因资讯	05-12 07:09
46	0	[Amend] Tender offer statement by Third Party	生化基因资讯	05-07 04:47
46	0	[Amend] Statement of Beneficial Ownership by Certain Investors	生化基因资讯	05-06 11:07
48	0	Statement of changes in beneficial ownership of securities	生化基因资讯	05-06 04:22
37	0	Statement of Beneficial Ownership by Certain Investors	生化基因资讯	04-30 05:44
45	0	Q1 2026 Biogen Earnings Presentation	生化基因资讯	04-30 05:13
40	0	Quarterly report [Sections 13 or 15(d)]	生化基因资讯	04-29 06:46
43	0	Current report, items 2.02 and 9.01	生化基因资讯	04-29 06:38
113	0	渤健预计财年调整后每股收益为14.25至15.25美元	生化基因资讯	04-29 06:29
43	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	生化基因资讯	04-29 04:51
46	0	Annual Report to Security Holders	生化基因资讯	04-29 04:51
44	0	Other definitive proxy statements	生化基因资讯	04-29 04:43
1205	0	OPC创业者黄婉菁：瞄准“长寿经济”押注传统文化基因+生物基因#OPC#创业	中国经营报	04-22 08:09
225	0	天境生物卖掉昔日核心管线	生化基因资讯	04-21 08:14
61	0	Tender offer statement by Third Party	生化基因资讯	04-14 07:07
66	0	Written communication relating to an issuer or third party	生化基因资讯	04-08 05:11
95	0	Initial statement of beneficial ownership of securities	生化基因资讯	04-07 06:13
54	0	General Statement of Acquisition of Beneficial Ownership	生化基因资讯	04-07 06:12
61	0	Current report, item 2.02	生化基因资讯	04-06 06:36
104	0	Written communication relating to an issuer or third party	生化基因资讯	04-04 05:15
65	0	Statement of changes in beneficial ownership of securities	生化基因资讯	04-04 04:09
52	0	Written communication relating to an issuer or third party	生化基因资讯	04-01 10:10
66	0	Current report, items 1.01, 8.01, and 9.01	生化基因资讯	04-01 05:23
54	0	Written communication relating to an issuer or third party	生化基因资讯	04-01 05:16
388	1	渤健将斥资56亿美元收购制药公司Apellis	生化基因资讯	03-31 08:33
71	0	[Amend] Statement of Beneficial Ownership by Certain Investors	生化基因资讯	03-27 04:24
59	0	Current report, item 5.02	生化基因资讯	03-12 06:07
69	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:20
74	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:20
73	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:18
70	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:17
74	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:13
72	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:13
66	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:11
84	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:11
80	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:09
71	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-18 09:07
73	0	Current report, items 5.02 and 8.01	生化基因资讯	02-12 06:12
74	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:09
72	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:09
81	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:06
70	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:06
73	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:04
89	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:04
70	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:01
73	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 06:01
77	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 05:59
78	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-11 05:58
89	0	Report of proposed sale of securities	生化基因资讯	02-09 11:16
64	0	北陆药业发来贺电	股友8360i96m19	02-07 03:53
1547	5	Biotech一哥，扔出王炸	瞪羚社	11-17 09:28
73	0	Q4 and Full Year 2025 Biogen Earnings Presentation	生化基因资讯	02-06 09:28
80	0	Annual report [Section 13 and 15(d), not S-K Item 405]	生化基因资讯	02-06 08:41
72	0	Current report, items 2.02 and 9.01	生化基因资讯	02-06 07:59
72	0	Statement of Beneficial Ownership by Certain Investors	生化基因资讯	02-06 02:20
85	0	Statement of changes in beneficial ownership of securities	生化基因资讯	02-04 06:21
83	0	Report of proposed sale of securities	生化基因资讯	02-03 12:11
79	1	医药避险来金马不痴呆	账户已注销	12-10 08:50
96	0	Current report, item 2.02	生化基因资讯	01-14 08:03
1746	0	骐骥驰骋！2026年马年春晚吉祥物发布	行业公司论	12-18 12:05
333	0	富国银行上调渤健目标价至190美元	格隆汇	12-11 11:36
80	0	Statement of changes in beneficial ownership of securities	生化基因资讯	12-04 05:45
72	0	通化金马发来贺电	账户已注销	11-24 10:47
72	0	[Amend] Statement of Beneficial Ownership by Certain Investors	生化基因资讯	11-14 09:30
84	0	Statement of Beneficial Ownership by Certain Investors	生化基因资讯	11-10 09:19
88	0	Statement of changes in beneficial ownership of securities	生化基因资讯	11-05 05:19
66	0	通化金马起飞	资深谋划师	11-04 11:10
88	0	Quarterly report [Sections 13 or 15(d)]	生化基因资讯	10-30 06:40
84	0	Current report, items 2.02 and 9.01	生化基因资讯	10-30 06:38
86	0	Current report, items 2.02 and 9.01	生化基因资讯	10-15 04:24
86	0	Statement of changes in beneficial ownership of securities	生化基因资讯	10-07 01:22
1135	2	渤健和日本卫材用于治疗阿尔茨海默症的家庭版疗法获得美国FDA批准	生化基因资讯	08-30 05:55
101	0	Statement of changes in beneficial ownership of securities	生化基因资讯	09-03 05:58
96	0	Report of proposed sale of securities	生化基因资讯	09-03 12:56

emytylist